α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01475-1
- By:
- Publication type:
- Article
Works by Lu, Tiange
Results: 15
1
2
Targeting PTGDS Promotes ferroptosis in peripheral T cell lymphoma through regulating HMOX1-mediated iron metabolism: Translational Therapeutics.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 4, p. 384, doi. 10.1038/s41416-024-02919-w
- By:
- Publication type:
- Article
3
Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell Lymphoma.
- Published in:
- International Journal of Biological Sciences, 2023, v. 19, n. 14, p. 4627, doi. 10.7150/ijbs.85236
- By:
- Publication type:
- Article
4
Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2601, doi. 10.1007/s10238-023-00996-4
- By:
- Publication type:
- Article
5
Novel insights into the m6A-RNA methyltransferase METTL3 in cancer.
- Published in:
- Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00278-9
- By:
- Publication type:
- Article
6
Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11401-4
- By:
- Publication type:
- Article
7
Targeting TTK Inhibits Tumorigenesis of T‐Cell Lymphoma Through Dephosphorylating p38α and Activating AMPK/mTOR Pathway.
- Published in:
- Advanced Science, 2025, v. 12, n. 10, p. 1, doi. 10.1002/advs.202413990
- By:
- Publication type:
- Article
8
KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway.
- Published in:
- Cellular & Molecular Biology Letters, 2023, v. 28, n. 1, p. 1, doi. 10.1186/s11658-023-00445-w
- By:
- Publication type:
- Article
9
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01311-6
- By:
- Publication type:
- Article
10
Single-cell transcriptome analysis profiles the expression features of TMEM173 in BM cells of high-risk B-cell acute lymphoblastic leukemia.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10830-5
- By:
- Publication type:
- Article
11
Antidepressants and Risk of Liver Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 12, p. 1398, doi. 10.1177/10600280221143512
- By:
- Publication type:
- Article
12
Maintenance and consolidation strategies for patients with untreated advanced follicular lymphoma: A systematic review and network meta‐analysis of randomized trials.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 7, p. 1072, doi. 10.1002/cncr.35137
- By:
- Publication type:
- Article
13
N‐acetyltransferase 10 facilitates tumorigenesis of diffuse large B‐cell lymphoma by regulating AMPK/mTOR signalling through N4‐acetylcytidine modification of SLC30A9.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 7, p. 1, doi. 10.1002/ctm2.1747
- By:
- Publication type:
- Article
14
CAR-NK cell therapy: latest updates from the 2024 ASH annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01677-3
- By:
- Publication type:
- Article
15
Derivation and validation of a lipid-covered prognostic model for mature T-cell lymphomas.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-02042-3
- By:
- Publication type:
- Article